Market: NYQ |
Currency:
Address:
📈 RAC Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
-
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for RAC
No earnings history available for this symbol.
📰 Related News & Research
-
Straco Corporation Limited to Release Second Half and Full Year 2025 Financial Results on 27 February 2026 | Dividend Details Not Announced 1
February 13, 2026
Straco Corporation Limited: Forthcoming Financial Results Announcement Straco Corporation Limited has announced that it will release its financial results for the Second Half and Full…
-
iX Biopharma Upsizes Share Placement, Raises S$15 Million to Fund U.S. Government Contract and Repay Debts 12
February 13, 2026
iX Biopharma Announces Upsized S\$15 Million Share Placement Amid Strong Demand iX Biopharma Upsizes Share Placement to S\$15 Million Following Strong Investor Demand Singapore, 13…
-
U.S. Government Awards iX Biopharma $41M Contract to Develop Wafermine® Ketamine Wafer for Military Pain Relief
February 12, 2026
iX Biopharma Secures US\$41 Million U.S. Government Contract for Wafermine® Development iX Biopharma Awarded US\$41 Million U.S. Defense Contract to Advance Wafermine® for Acute Pain…
-
iX Biopharma Awarded US$41 Million U.S. Defense Contract for Development of Non-Opioid Sublingual Ketamine Pain Treatment Wafermine® 1
February 12, 2026
iX Biopharma Awarded US\$41 Million U.S. Government Contract iX Biopharma Secures US\$41 Million U.S. Department of Defense Contract for Non-Opioid Pain Treatment: A Potential Game-Changer…
-
iX Biopharma Announces S$6 Million Share Placement to Fund U.S. Government Contract Execution
February 12, 2026
html iX Biopharma Announces S\$6 Million Placement to Fund U.S. Government Contract iX Biopharma Announces S\$6 Million Placement to Fund U.S. Government Contract Key Points…
-
Far East Hospitality Trust 2H/FY2025 Results: Revenue Growth, Portfolio Diversification & Attractive 6.1% Dividend Yield (DPS 3.70 cents)
February 11, 2026
Far East Hospitality Trust FY2025 Results: A Solid Year with Signs of Stabilization Far East Hospitality Trust (Far East H-Trust) delivered its FY2025 results in…
-
King Wan Corporation Secures S$6.4 Million M&E Contract for Admiralty Lane Public Housing Project
February 11, 2026
King Wan Corporation Secures S\$6.4 Million M&E Contract for Public Housing Project King Wan Corporation Secures S\$6.4 Million M&E Contract for Public Housing Project Singapore,…
-
CapitaLand Ascendas REIT 2026 Analysis: Strong Portfolio Growth, Attractive Yields & Top S-REIT Pick
February 10, 2026
Broker Name: OCBC Group Research Date of Report: 6 February 2026 Excerpt from OCBC Group Research report. Report Summary CapitaLand Ascendas REIT (CLAR) is Singapore’s…
-
Ever Glory United Holdings Secures S$508 Million in New Contracts, Boosting Order Book to S$732.8 Million for 2025
February 6, 2026
Ever Glory United Holdings Secures Landmark S\$508 Million in New Contracts, Elevates Order Book to S\$732.8 Million Ever Glory United Holdings Secures Landmark S\$508 Million…
-
Keppel REIT 2026 Update: Strong Portfolio Growth, Resilient Office Rents, and Attractive Investment Outlook
February 5, 2026
Broker Name: OCBC Group Research Date of Report: 4 February 2026 Excerpt from OCBC Group Research report. Report Summary Keppel REIT (KREIT) reported a 6.6%…
🔍 View more Reports